Enovis Corporation
ENOVNYSEHealthcareMedical Devices
As of Oct 23, 2026 close
- Market cap
- $1.21B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $16.70$34.28
- Volume (live)
- -
- Avg. volume (3M)
- 1.46M
Enovis (ENOV) Stock Price & Financial Analysis
Enovis Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $20.86 - $21.70 |
|---|---|
| 52-Week High | $34.28 |
| 52-Week Low | $16.70 |
| Open | $21.39 |
| Volume (last close) | 954.30K |
| Average Volume (3M) | 1.46M |
| Revenue (TTM) | 2.34B |
|---|---|
| Net Income (TTM) | -539.31M |
| Free Cash Flow (TTM) | 4.57M |
| EPS (TTM) | −$9.35 |
| Profit Margin | -23.01% |
| Operating Margin | 4.15% |
| Return on Equity (ROE) | -36.46% |
| Debt to Equity | 0.87 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 1.21B |
|---|---|
| Shares Outstanding | 57.60M |
| Price to Sales (P/S) | 0.52 |
| Price to Book (P/B) | 0.82 |
| EV/EBITDA | 6.82 |
| 50-Day MA | $20.67 |
|---|---|
| 200-Day MA | $23.30 |
| 1-Year Change | −33.65% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Enovis at a Glance
As of the Oct 23, 2026 close, Enovis (ENOV) has a market capitalization of $1.21B. The stock trades at 0.5× sales. Over the trailing twelve months it lost $539.31M on revenue of $2.34B and generated $4.57M of free cash flow. Revenue grew 4.7% year over year.
As of its latest reported balance sheet, it holds $12.56M in cash and securities against $1.29B of debt, a net debt position of $1.28B.
Enovis does not currently pay a dividend.
The share price is down 33.7% over the past year. At $21.08 (the Oct 23, 2026 close) it sits within its 52-week range of $16.70 to $34.28, below its 200-day moving average of $23.30.
Based on 11 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $36.20, 71.7% above the Oct 23, 2026 close.
Frequently Asked Questions About Enovis
What is the current stock price for ENOV?
As of the Oct 23, 2026 close, ENOV stock trades at $21.08. The 52-week range is $16.70–$34.28, with a day range of $20.86–$21.70.
What is the P/E ratio for ENOV?
The P/E ratio (Price-to-Earnings) for ENOV is shown in the Key Statistics section. This valuation metric helps compare Enovis Corporation to industry peers.
Does ENOV pay dividends?
Enovis does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for ENOV?
Based on ratings from 11 professional analysts over the last 90 days, the consensus for ENOV is Buy. The average 12-month price target is $36.20, a 71.7% upside from the Oct 23, 2026 close of $21.08.
What is the market cap of ENOV?
As of the Oct 23, 2026 close, Enovis's market capitalization is $1.21B, classifying it as a small-cap company. Enovis operates in the Healthcare sector within the Medical Devices industry.